- cafead   Jul 30, 2024 at 06:42: PM
via Six months after surviving a patent challenge involving its $3.2 million gene therapy, Sarepta faces a new lawsuit from another gene therapy developer claiming the approved treatment infringes its active patents.
article source
article source